ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,653Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 300

$424K Total Retail Price of All Prescriptions

Rank: 42 out of 300

375 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 375 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

22% of this provider’s 375 patients filled at least one prescription for a schedule three drug, compared to an average of 21%.

Risky Drugs to Seniors

3% of this provider’s 7,469 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 5%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $75 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 422 242 S3 1 1
LISINOPRIL 303 248 2 7
AMLODIPINE BESYLATE 292 250 3 4
SIMVASTATIN 290 255 4 3
OMEPRAZOLE 287 219 5 2
ATENOLOL 287 245 5 27
FUROSEMIDE 274 183 7 5
LEVOTHYROXINE SODIUM 271 252 8 12
CARVEDILOL 189 128 9 8
METFORMIN HCL ER 178 157 10 100
RANITIDINE HCL 177 107 11 63
HYDROCHLOROTHIAZIDE 152 121 12 21
GLYBURIDE 151 130 R 13 141
PRAVASTATIN SODIUM 142 113 14 17
TORSEMIDE 140 128 15 110
POTASSIUM CHLORIDE 127 92 16 20
LOSARTAN POTASSIUM 120 103 17 29
RAMIPRIL 116 100 18 57
ALENDRONATE SODIUM 115 107 19 79
METFORMIN HCL 113 86 20 24
CEPHALEXIN 109 77 21 82
FENOFIBRATE 104 80 22 73
ATORVASTATIN CALCIUM 96 77 23 13
TRAZODONE HCL 94 73 24 51
BENAZEPRIL HCL 89 84 25 122
ENALAPRIL MALEATE 81 57 26 56
TAMSULOSIN HCL 81 81 26 9
CITALOPRAM HBR 79 63 28 46
MELOXICAM 76 43 29 14
ZOLPIDEM TARTRATE 75 62 30 16
CLOPIDOGREL 75 74 30 18
DONEPEZIL HCL 73 73 32 33
DIOVAN 69 57 33 84
CARISOPRODOL 65 22 R 34 28
TRAMADOL HCL 65 36 34 11
ALLOPURINOL 64 28 36 64
METOLAZONE 62 36 37 144
BYSTOLIC 61 57 38 226
WARFARIN SODIUM 61 39 38 23
DOXAZOSIN MESYLATE 58 56 40 94
PAROXETINE HCL 57 36 41 103
NAPROXEN 57 49 41 159
CRESTOR 54 36 43 49
METOPROLOL TARTRATE 53 52 44 26
METOPROLOL SUCCINATE 53 45 44 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 38 44 47
SERTRALINE HCL 52 23 47 40
PREDNISONE 52 36 47 50
FLUTICASONE PROPIONATE 51 40 49 34
ZETIA 51 40 49 151
HYDRALAZINE HCL 50 40 51 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 17, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.